Scientists hail the success of PMR (percutaneous transmyocardial revascularisation) trials and predict it could replac more invasive laser technique
This article was originally published in Clinica
Preliminary results from the largest trial to date of percutaneous transmyocardial revascularisation (PMR) have led the main investigator to predict that the technique will become the treatment of choice for patients with severe angina who can not undergo bypass or angioplasty.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.